Main Article Content

Zara Idrees
Arshad Khushdil
Ujala Zakir
Zeeshan Ahmed



Maple syrup urine disease (MSUD) is an inborn error of amino acid metabolism secondary to enzyme defect that breaks down branched-chain amino acid (BCAA). Accumulation of these amino acids and their corresponding ketoacids in the body progresses to neurodegenerative disorders and encephalopathy in undiagnosed infants. We report a case of 46 days old baby with classical clinical and biochemical findings consistent with MSUD. Baby was investigated for inborn error of metabolism after he developed lethargy and his oral intake reduced on fifth day of life. A diagnosis of MSUD was established after analysis of plasma and CSF amino acid profile.  Baby was treated accordingly and improvement in his condition was seen afterwards. 

KEYWORDS:Maple Syrup Urine Disease (MeSH); Amino Acids (MeSH); Amino Acids, Branched-Chain (MeSH); Infant (MeSH), Cerebrospinal Fluid (MeSH).


Article Details

How to Cite
Idrees, Z., A. Khushdil, U. Zakir, and Z. Ahmed. “CLASSIC MAPLE SYRUP URINE DISEASE IN A 46-DAY-OLD BABY: A CASE REPORT”. KHYBER MEDICAL UNIVERSITY JOURNAL, vol. 10, no. 1, Mar. 2018, pp. 44-46,
Case Report



Blackburn PR, Gass JM, Vairo FP, Farnham KM, Atwal HK, Macklin S, et al. Maple syrup urine disease: mechanisms and management. Appl Clin Genet 2017;10:57-66. DOI: 10.2147/TACG.S125962.

van Calcar S. Nutrition Management of Maple Syrup Urine Disease. In: Bernstein L., Rohr F., Helm J. (eds) Nutrition Management of Inherited Metabolic Diseases. 2015, Springer, Cham, Switzerland. DOI:10.1007/978-3-319-14621-8_16.

Cheng A, Han L, Feng Y, Li H, Yao R, Wang D et al. MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases. Diagn Interv Radiol 2017; 23:398–402. DOI: 10.5152/dir.2017.16466.

Chuang DT, Shih VE, Max Wynn R. Maple Syrup Urine Disease (Branched-Chain Ketoaciduria). In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson KM, Mitchell G (Eds). The Online Metabolic and Molecular Bases of Inherited Disease. 2016. McGraw-Hill, New York.

Sherazi NA, Khan AH, Jafri L, Jamil A, Khan NA, Afroze B. Selective Screening for Organic Acidurias and Amino Acidopathies in Pakistani Children. J Coll Physicians Surg Pak 2017;27(4):218-221. DOI: 2593.

Morton DH, Strauss KA, Robinson DL, Puffenberger EG, Kelley RI. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics. 2002;109(6):999–1008

Köse M, Canda E, Kagnici M, Uçar SK, Çoker M. A Patient with MSUD: Acute Management with Sodium Phenylacetate/Sodium Benzoate and Sodium Phenylbutyrate. Case Rep Pediatr 2017;2017:1045031. DOI: 10.1155/2017/1045031.

Jan W, Zimmerman RA, Wang ZJ, Berry GT, Kaplan PB, Kaye EM. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 2003;45(6):393-9. DOI: 10.1007/s00234-003-0955-7

Strauss KA, Puffenberger EG, Morton DH. Maple Syrup Urine Disease. 2006 Jan 30 [Updated 2013 May 9]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018. Available from:

Scriver CR, Mackenzie S, Clow CL, Delvin E. Thiamine-responsive maple-syrup-urine disease. Lancet 1971;1(7694):310–2.

Most read articles by the same author(s)